Gene · 2946
Papers3,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in osteoarthritis by integrating bioinformatics and machine learning. | Front Immunol | 2025 | 40909283 | PubTator, text mining | PubMed |
| Distinct Effects of PFOS and OBS on Neurotoxicity via PMK-1 Mediated Pathway in Caenorhabditis elegans. | Toxics | 2025 | 40863938 | PubTator, text mining | PubMed |
| Exposure to Mitochondrial Toxins: An In Vitro Study of Energy Depletion and Oxidative Stress in Driving Dopaminergic Neuronal Death in MN9D Cells. | Toxics | 2025 | 40863913 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications. | Int J Mol Sci | 2025 | 40806731 | PubTator, text mining | PubMed |
| Effect of egg white peptides‑selenium chelate against APAP-induced damage in HepG2 cells and C. elegans via Nrf2 signaling. | Food Chem | 2025 | 40675083 | PubTator, text mining | PubMed |
| Interaction networks among miRNA, protein, and metabolite fingerprints identify the regulatory networks and key players in the pathogenesis of diabetic cardiomyopathy. | Front Cell Dev Biol | 2025 | 40661146 | PubTator, text mining | PubMed |
| S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker. | Front Oncol | 2025 | 40567612 | PubTator, text mining | PubMed |
| Role of ADME genes in breast cancer prognosis: an analysis of risk scoring models based on multi-omics data. | Front Oncol | 2025 | 40535120 | PubTator, text mining | PubMed |
| Deciphering the Overlapping Immune Mechanism Between Depression and Breast Cancer. | Int J Mol Sci | 2025 | 40508038 | PubTator, text mining | PubMed |
| Loss of YTHDF1 suppresses the progression of malignant rhabdoid tumor of the kidney by regulating Glutathione S-transferase Mu 2 (GSTM2). | Cell Biol Toxicol | 2025 | 40481948 | PubTator, text mining | PubMed |
| Identifying diagnostic markers and establishing prognostic model for lung cancer based on lung cancer-derived exosomal genes. | Cancer Biomark | 2025 | 40179422 | PubTator, text mining | PubMed |
| Seminal plasma proteomics of asymptomatic COVID-19 patients reveals disruption of male reproductive function. | BMC Genomics | 2025 | 40119256 | PubTator, text mining | PubMed |
| Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell-cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer. | Discov Oncol | 2025 | 39946051 | PubTator, text mining | PubMed |
| Isozyme-specific inhibition of GSTP1-1: a crucial element in cancer-targeting drugs. | RSC Med Chem | 2025 | 39917632 | PubTator, text mining | PubMed |
| PLK1: A Promising Therapeutic Target for Prostate Cancer Treatment. | Serican J Med | 2024 | 42376209 | PubTator, text mining | PubMed |
| N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. | Glycobiology | 2024 | 39360848 | PubTator, text mining | PubMed |
| Detection of differentially methylated CpGs between tumour and adjacent benign cells in diagnostic prostate cancer samples. | Sci Rep | 2024 | 39095452 | PubTator, text mining | PubMed |
| Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model. | Biomolecules | 2024 | 38927076 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer. | Cell Biol Int | 2024 | 38922769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2946/papers?page=2